A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study

Rochester Ophthalmological Group, PC, Rochester

Seidenberg Protzko Eye Associates, Havre de Grace

Tidewater Clinical Research, Virginia Beach

Clayton Eye Clinical Research, LLC, Morrow

International Eye Associates PA, Ormond Beach

East Florida Eye Institute, Stuart

VRF Eye Specialty Group, Memphis

Abrams Eye Center, Cleveland

Great Lakes Eye Care P.C, Saint Joseph

Silverstein Eye Centers, Kansas City

Baylor College of Medicine Alkek Eye Center, Houston

Stacy R. Smith M.D. P.C., Salt Lake City

Arizona Eye Center, Chandler

AdvanceMed Clinical Research, Las Vegas

United Medical Research Inst, Inglewood

Global Research Management, Glendale

AdvanceMed Clinical Research, San Diego

M & M Eye Institute, Prescott

Eye Research Foundation, Newport Beach

North Bay Eye Associates Inc., Petaluma

Sacramento Eye Consultants, Sacramento

Michael K. Tran, MD, Inc., Westminster

Haas Vision Center, Colorado Springs

Florida Ophthalmic Institute, Gainesville

St. Michaels Eye Laser Institute, Largo

Discover Vision Centers, Independence

Comprehensive Eye Care Ltd., Washington

Asheville Eye Associates, Asheville

Total Eye Care PA, Memphis

Glaucoma Associates of Texas, Dallas

Houston Eye Associates HEA - Gramercy Location, Houston

The Eye Clinic of Texas, League City

Medical Center Ophthalmology Associates, San Antonio

Vistar Eye Center, Roanoke